2269.HKESG•prnewswire•August 28, 2025 at 09:00 AM

WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi

Sentiment:Positive (70)

Summary

Committed to net-zero across the value chain by 2050 Aligned with 1.5°C mitigation pathways, the most ambitious SBTi designation Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, Aug. 28, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 28, 2025 by prnewswire